Senior Risk Management Lead
AbbVie
Summary
The Senior Risk Management Lead (Senior RML) is a senior-level subject matter expert responsible for executing and advancing risk management strategies across multiple clinical programs within designated therapeutic areas. This role bridges operational risk management and strategic oversight, serving as a high-level resource for portfolio- and program-level risk identification, assessment, mitigation, and continuous improvement. The Senior RML partners closely with study teams, cross-functional stakeholders, and leadership, ensuring robust implementation and ongoing optimization of AbbVie's Risk-Based Quality Management (RBQM) model, enhancing data-driven decision making, and fostering a proactive risk culture to support high-quality, compliant clinical trial execution.
Job description
Key Responsibilities
- Lead and oversee end-to-end adoption of the RBQM model across multiple, complex clinical studies and/or therapeutic areas; serve as the primary point of contact for escalated or complex risk issues.
- Collaborate with Therapeutic Area teams, Clinical Study Leadership, and Integrated Evidence Strategy to embed critical-to-quality elements in protocol design and operational plans.
- Drive portfolio-level risk identification, assessment, and mitigation—facilitate and steer RAMP (Risk Assessment and Mitigation Planning) meetings, ensuring robust documentation and actionable mitigation strategies.
- Guide and coach Risk Management Leads and study teams in risk methodology, strategic risk controls, the definition of Key Risk Indicators (KRIs), and continuous process maturity.
- Analyze quality, performance, and risk signals across studies and programs using advanced data analytics and dashboards; identify trends, forecast risk areas, and recommend data-driven interventions.
- Lead or support the development of therapeutic area risk insights, mitigation plans, and executive summaries; present key findings to leadership and support resource planning (e.g., RAMP entry work, risk-based study modifications).
- Support the alignment and consistency of risk management expectations with global monitoring strategies and regulatory guidance (ICH-GCP E6(R2), FDA, EMA).
- Serve as back-up to the Director, Risk Management Leads, deputizing for strategic cross-functional initiatives, process improvement efforts, best practice standardization, and training.
- Support inspection readiness, audits, and regulatory compliance activities in collaboration with Quality Assurance and Clinical Process Compliance.
- Foster a culture of transparency, knowledge sharing, and continuous improvement in risk management for clinical development.
Qualifications
- Bachelor's degree in life sciences, pharmacy, nursing or related field; advanced degree (Master's, PharmD, PhD, MD) preferred.
- Minimum of 12 years of experience in clinical research, clinical operations, or risk management for clinical trials, with substantial experience in risk-based quality management (RBQM).
- Demonstrated expertise executing portfolio/program-level risk assessment, RAMP processes, and implementing risk-based modifications in clinical programs.
- In-depth knowledge of regulatory guidelines (FDA, EMA, ICH), global GCP requirements, and risk management best practices.
- Advanced skills in data analytics and the use of visualization tools (Excel, Power BI, Tableau) for risk oversight and reporting.
- Strong leadership abilities, including experience mentoring others, facilitating change, and influencing cross-functional and senior/executive stakeholders.
- Experience with process improvement, best practice standardization, and inspection readiness/audit response.
- Professional risk management certifications (e.g., ASQ, CRM, PRM) are highly desirable.
- Excellent communication, presentation, and interpersonal skills.
- Fluent in English; additional language proficiency is a plus.
Requirements
- Bachelor's degree in life sciences, pharmacy, nursing or related field
- Advanced degree (Master's, PharmD, PhD, MD) preferred
- Minimum of 12 years of experience in clinical research, clinical operations, or risk management for clinical trials
- Substantial experience in risk-based quality management (RBQM)
- Demonstrated expertise executing portfolio/program-level risk assessment, RAMP processes, and implementing risk-based modifications in clinical programs
- In-depth knowledge of regulatory guidelines (FDA, EMA, ICH), global GCP requirements, and risk management best practices
- Advanced skills in data analytics and the use of visualization tools (Excel, Power BI, Tableau)
- Strong leadership abilities, including experience mentoring others, facilitating change, and influencing cross-functional and senior/executive stakeholders
- Experience with process improvement, best practice standardization, and inspection readiness/audit response
- Professional risk management certifications (e.g., ASQ, CRM, PRM) are highly desirable
- Excellent communication, presentation, and interpersonal skills
- Fluent in English; additional language proficiency is a plus
Benefits
- Paid time off
- Medical, Dental & Vision
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.